Donald G. Morris

Once-daily intravenous busulfan given with fludarabine as conditioning for allogeneic stem cell transplantation: Study of pharmacokinetics and early clinical outcomes

Jeffrey A. Russell, Hai T. Tran, Diana Quinlan et al. · Biology of Blood and Marrow Transplantation · 2002 · 290 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas

Peter Forsyth, Howard Wong, Donald G. Morris et al. · British Journal of Cancer · 1999 · 259 citations

Medicine, Oncology, Pathology +13

Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas

Peter Forsyth, Hubert Wong, T D Laing et al. · British Journal of Cancer · 1999 · 224 citations · Full text

Medicine, Oncology, Pathology +13

Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340.

Anthony N. Price, Qiuling Shi, Donald G. Morris et al. · PubMed · 1999 · 136 citations

Medicine, Oncology, Pharmacology +17

Adult Recipients of Matched Related Donor Blood Cell Transplants Given Myeloablative Regimens Including Pretransplant Antithymocyte Globulin Have Lower Mortality Related to Graft-versus-Host Disease: A Matched Pair Analysis

James A. Russell, A. Robert Turner, Loree Larratt et al. · Biology of Blood and Marrow Transplantation · 2007 · 75 citations · Full text

Life Sciences, Hematology, Immunology +15